Experimental gene regulation therapy lowers levels of Tau protein in the brain and could protect against Alzheimer's
A research group involving the DZNE has successfully developed a new method of gene regulation that permanently reduces the protein "tau" in the adult brain. This could become the basis for new therapies against Alzheimer's and other neurodegenerative diseases.
DZNE and Eisai Enter Into Research Collaboration Agreement
The DZNE and Eisai Co., Ltd. announce that both parties have entered into a research collaboration agreement aiming to create potential novel treatments for neurodegenerative disorders.
The long-term study investigates which protection and risk factors influence the health of adults over the life span up to old age.
Welcome to our website, here you can inform yourself basically cookie-free.
We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.
